Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
Beijing Balance Medical Technology Co's 3-Year ROIIC % for the quarter that ended in Dec. 2025 was 15.62%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
SHSE:688198's 3-Year ROIIC % is ranked better than 66.2% of 793
companies
in the Medical Devices & Instruments industry
Industry Median: 1.47
vs SHSE:688198: 15.62
Beijing Balance Medical Technology Co (SHSE:688198) 3-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Beijing Balance Medical Technology Co 3-Year ROIIC % Related Terms
Beijing Balance Medical Technology Co 3-Year ROIIC % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Beijing Balance Medical Technology Co 3-Year ROIIC % Chart
SHSE:688198 vs ABT, SYK, MDT: 3-Year ROIIC % Comparison
For the Medical Devices subindustry, Beijing Balance Medical Technology Co's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Beijing Balance Medical Technology Co 3-Year ROIIC % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Beijing Balance Medical Technology Co's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Beijing Balance Medical Technology Co's 3-Year ROIIC % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Beijing Balance Medical Technology Co (SHSE:688198) has a 3-Year ROIIC % of 15.62 as of Dec. 2025. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Beijing Balance Medical Technology Co and its competitors. This is 122% above median its historical median of 7.03. According to the industry distribution chart, Beijing Balance Medical Technology Co ranks #268 out of 793 companies in the Medical Devices & Instruments industry, placing it in the top 33.8%.
Is Beijing Balance Medical Technology Co's 3-Year ROIIC % too high?
Beijing Balance Medical Technology Co's current 3-Year ROIIC % of 15.62 is 122% above median its 10-year median of 7.03. The Medical Devices & Instruments industry median 3-Year ROIIC % is 1.47. Beijing Balance Medical Technology Co's value of 15.62 is 962.6% above this industry median. Based on the distribution chart, Beijing Balance Medical Technology Co ranks #268 out of 793 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Beijing Balance Medical Technology Co has a GF Score™ of 88/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Beijing Balance Medical Technology Co's 3-Year ROIIC % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Beijing Balance Medical Technology Co ranks #268 out of 793 companies for 3-Year ROIIC %. This puts Beijing Balance Medical Technology Co in the upper half of its industry. The industry median 3-Year ROIIC % is 1.47. Beijing Balance Medical Technology Co's value of 15.62 is 962.6% above this benchmark. While the company's 10-year median is 7.03 vs. the industry median of 1.47, Beijing Balance Medical Technology Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Medical Devices & Instruments company?
The median 3-Year ROIIC % among Medical Devices & Instruments companies is 1.47, based on 793 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Beijing Balance Medical Technology Co's current 3-Year ROIIC % of 15.62 is 962.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Beijing Balance Medical Technology Co and its competitors. For the Medical Devices & Instruments industry, the median 3-Year ROIIC % is 1.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Beijing Balance Medical Technology Co's current 3-Year ROIIC % is 15.62, which is 122% above median its own 10-year median of 7.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Beijing Balance Medical Technology Co stock overvalued right now?
Based on GuruFocus' analysis, Beijing Balance Medical Technology Co (SHSE:688198) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥188.03, compared to a current price of ¥81.50 — trading 56.7% below its estimated fair value. The current 3-Year ROIIC % is 15.62, which is 122% above median its 10-year median of 7.03 and 962.6% above the Medical Devices & Instruments industry median of 1.47. Beijing Balance Medical Technology Co's overall GF Score™ is 88/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For Beijing Balance Medical Technology Co (SHSE:688198), the current 3-Year ROIIC % is 15.62 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Beijing Balance Medical Technology Co (SHSE:688198) Overvalued in 2026?
Based on GuruFocus' analysis, Beijing Balance Medical Technology Co stock appears to be undervalued.
The current stock price of ¥81.50 is trading 56.7% below its estimated GF Value™ of ¥188.03.
GuruFocus considers Beijing Balance Medical Technology Co to be Significantly Undervalued.
Key valuation signals for SHSE:688198:
3-Year ROIIC %: 15.62 (122% above median its 10-year median of 7.03)
GF Value™: ¥188.03 vs. price of ¥81.50 (56.7% below fair value)
Industry Position: 962.6% above the Medical Devices & Instruments median (#268 of 793)
No single metric tells the full story. See the SHSE:688198 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Beijing Balance Medical Technology Co Ltd is engaged in the research and development and production of animal-derived implantable medical devices. The company's products are used in heart valve replacement and repair, congenital heart disease implant intervention and surgical soft tissue repair.
88GF Score
Get the complete analysis for SHSE:688198
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688198 has been successfully added to your 
